Sana Biotechnology SANA Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Sana Biotechnology in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sana Biotechnology's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sana Biotechnology's restricted cash?
- Sana Biotechnology (SANA) reported restricted cash of $4.2M in Q1 2026.
- How has Sana Biotechnology's restricted cash changed year-over-year?
- Sana Biotechnology's restricted cash decreased by 0.0% year-over-year, from $4.2M to $4.2M.
- What is the long-term trend for Sana Biotechnology's restricted cash?
- Over 5 years (2020 to 2025), Sana Biotechnology's restricted cash has grown at a 14.4% compound annual growth rate (CAGR), from $2.14M to $4.2M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.